A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of IMG-007 in Adult Alopecia Areata Participants

Status:
Active, not recruiting

Trial end date:
2024-10-01

Target enrollment:

Participant gender:

The primary objective of the study is to evaluate the safety of IMG-007 in adults with Alopecia Areata.

Phase 1/Phase 2

Inmagene LLC